Atara Biotherapeutics Inc [ATRA] attracts people because of its fundamentals
The stock of Atara Biotherapeutics Inc (NASDAQ:ATRA) last traded at $0.66, down -4.65% from the previous session. Data from the available sources indicates that Atara Biotherapeutics Inc (NASDAQ:ATRA) is covered by 8 analysts. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of […]
There’s Something Awry at Atara Biotherapeutics Inc (NASDAQ:ATRA) Since Share Price Gets Ahead of Fundamentals
The stock of Atara Biotherapeutics Inc (NASDAQ:ATRA) last traded at $0.57, up 13.22% from the previous session. Data from the available sources indicates that Atara Biotherapeutics Inc (NASDAQ:ATRA) is covered by 8 analysts. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of […]
An overview of Atara Biotherapeutics Inc’s (ATRA) institutional holdings
The price of Atara Biotherapeutics Inc (NASDAQ:ATRA) shares last traded on Wall Street fell -4.25% to $0.23. Based on available information, 9 analysts follow Atara Biotherapeutics Inc (NASDAQ:ATRA). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $28.00 and a low of […]
Stocks like Atara Biotherapeutics Inc. [ATRA] still have plenty of sunny days ahead
Stocks of Atara Biotherapeutics Inc. (NASDAQ:ATRA) traded higher last session on Wall Street, up 7.28% to $2.21. According to the data, Atara Biotherapeutics Inc. (NASDAQ:ATRA) has 9 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $31.00 and […]
Stocks like Atara Biotherapeutics Inc. [ATRA] still have plenty of sunny days ahead
In yesterday’s Wall Street session, Atara Biotherapeutics Inc. (NASDAQ:ATRA) shares traded at $2.18, up 11.79% from the previous session. As of this writing, 9 analysts cover Atara Biotherapeutics Inc. (NASDAQ:ATRA). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $31.00 and a […]
